MorphoSys is headquartered in Planegg, Germany.
MorphoSys disclosed revenue of 278M EUR for 2022 and 180M EUR for 2021.
MorphoSys is a life science company.
MorphoSys was founded in 1992.
MorphoSys is a global biopharmaceutical company developing innovative medicines in oncology. MorphoSys was formed in 1992 and is based in Planegg, Germany.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | 2 | 1 | - | - | - | - | 3 |
| vol | $1.7B | $1.7B | ||||||
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $60M | $60M | ||||||
| 4 | ||||||||
| Financial | Deals |
|---|---|
|
Goldman Sachs |
1 |
| Legal | Deals |
|---|---|
|
Skadden, Arps, Slate, Meagher & Flom |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
